{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:50:27Z","timestamp":1791809427413,"version":"4.3.4"},"reference-count":11,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/j.radonc.2026.111750","type":"journal-article","created":{"date-parts":[[2026,8,30]],"date-time":"2026-08-30T21:45:01Z","timestamp":1788126301000},"page":"111750","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Comment to letter to the editor: Patient selection for proton therapy in lung cancer: Nationwide external validation and model update of a prognostic model for 2-year mortality including mean heart dose"],"prefix":"10.1016","volume":"224","author":[{"given":"Judith","family":"van Loon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Wijsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9173-279X","authenticated-orcid":false,"given":"L.","family":"Boersma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.A.","family":"Langendijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Krol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Schuit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"van der Schaaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Stam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Monshouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.B.","family":"Reitsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"van Doorn-Wink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2026.111750_b0005","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacc.2019.03.500","article-title":"Cardiac radiation dose, cardiac disease, and mortality in patients with lung cancer","author":"Atkins","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.radonc.2026.111750_b0010","doi-asserted-by":"crossref","DOI":"10.1016\/j.clon.2023.11.029","article-title":"The Association of Incidental Radiation Dose to the heart base with overall survival and cardiac events after curative-intent radiotherapy for non-small cell lung cancer: results from the NI-HEART study","author":"Walls","year":"2024","journal-title":"Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111750_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2020.06.014","article-title":"Incidence and onset of severe cardiac events after radiotherapy for esophageal cancer","author":"Wang","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111750_b0020","article-title":"Heart Dosimetric Parameters were Associated with Cardiac events and overall survival for patients with locally advanced esophageal cancer receiving definitive radiotherapy","author":"Cai","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/j.radonc.2026.111750_b0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.prro.2021.01.004","article-title":"A multi-institutional analysis of radiation dosimetric predictors of toxicity after trimodality therapy for esophageal cancer","author":"Garant","year":"2021","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.radonc.2026.111750_b0030","doi-asserted-by":"crossref","DOI":"10.1182\/blood-2016-09-740332","article-title":"Risk of heart failure in survivors of Hodgkin lymphoma: effects of cardiac exposure to radiation and anthracyclines","author":"Van Nimwegen","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.radonc.2026.111750_b0035","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1209825","article-title":"Risk of ischemic heart disease in women after radiotherapy for breast cancer","author":"Darby","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/j.radonc.2026.111750_b0040","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.71.6142","article-title":"Cardiac events after radiation therapy: combined analysis of prospective multicenter trials for locally advanced non-small-cell lung cancer","author":"Dess","year":"2017","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.radonc.2026.111750_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2020.06.008","article-title":"Radiotherapy-related lymphopenia affects overall survival in patients with lung cancer","author":"Abravan","year":"2020","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.radonc.2026.111750_b0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0964-7","article-title":"Myocardial infarction accelerates breast cancer via innate immune reprogramming","author":"Koelwyn","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/j.radonc.2026.111750_b0055","article-title":"External validation of a lung cancer-based prediction model for two-year mortality in esophageal cancer patient cohorts","author":"Berb\u00e9e","year":"2024","journal-title":"Radiother Oncol"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600589X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402600589X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T12:39:58Z","timestamp":1791808798000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402600589X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,11]]},"references-count":11,"alternative-id":["S016781402600589X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111750","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comment to letter to the editor: Patient selection for proton therapy in lung cancer: Nationwide external validation and model update of a prognostic model for 2-year mortality including mean heart dose","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2026.111750","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111750"}}